Back

The liver compensates for zonal loss of glucose 6-phosphatase to prevent glycogen storage disease

Liang, R. J.; Cai, L.; Nguyen, P. T.; Kelekar, S.; Cervantes, M.; Tippetts, T.; Chen, E.; Ribas, R.; Ryan, A.; Chou, J.; sun, r. c.; Zhu, H.; DeBerardinis, R. J.

2026-07-28 physiology
10.64898/2026.07.26.740786 bioRxiv
Show abstract

The liver is organized into spatial zones with distinct metabolic roles, but how this architecture contributes to disease remains unclear. Glucose production is concentrated in periportal hepatocytes and depends on G6PC1; loss of this enzyme causes glycogen storage disease type Ia (GSD1a). We tested whether G6PC1 loss in specific zones, including its primary periportal location, is sufficient to cause disease. Unexpectedly, loss of G6pc1 in any single zone caused local glycogen accumulation but did not produce the systemic metabolic abnormalities or liver tumors seen after whole-liver deletion. Instead, disease developed only after near-complete loss of G6pc1 across the entire liver. These findings show that organ-wide compensation preserves metabolic homeostasis and suppresses tumorigenesis despite localized disruption. TeaserSpatial G6pc1 loss causes local glycogen storage without systemic metabolic disease.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.